SERPINA3 and cancer: In vitro stimulation of the human colon cancer cell line HT29 identified SerpinA3 as a driver of cancer cell proliferation via AKT pathway activation, highlighting the protein SerpinA3, which is released from failing hearts, as a potential driver of colon cancer tumorigenesis.